From 1 November 2023, the Government is funding an important blood test called the ‘NT-proBNP’ test for Australians living with Scleroderma, also known as systemic sclerosis (SSc). The test assesses your risk of having a condition called Pulmonary Arterial Hypertension (PAH), which is more common in people with Scleroderma. Read the information below or chat to your doctor to learn more.